Cargando…
The Runx transcriptional co-activator, CBFβ, is essential for invasion of breast cancer cells
BACKGROUND: The transcription factor Runx2 has an established role in cancers that metastasize to bone. In metastatic breast cancer cells Runx2 is overexpressed and contributes to the invasive capacity of the cells by regulating the expression of several invasion genes. CBFβ is a transcriptional co-...
Autores principales: | Mendoza-Villanueva, Daniel, Deng, Wensheng, Lopez-Camacho, Cesar, Shore, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905338/ https://www.ncbi.nlm.nih.gov/pubmed/20591170 http://dx.doi.org/10.1186/1476-4598-9-171 |
Ejemplares similares
-
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin
por: Mendoza-Villanueva, Daniel, et al.
Publicado: (2011) -
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
por: Illendula, Anuradha, et al.
Publicado: (2016) -
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
por: Khan, Adiba S., et al.
Publicado: (2023) -
Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis
por: Anderson, Brett D., et al.
Publicado: (2015) -
Essential functions of Runx/Cbfβ in gut conventional dendritic cells for priming Rorγt(+) T cells
por: Tenno, Mari, et al.
Publicado: (2019)